SIBN News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

SI

Mkt Cap

$882.2M

Volume

958.28K

Next Earnings

November 9th

Loading chart

SI

SIBNSI-BONE, Inc. Common Stock

SIBN

Pay with—

Available Balance0.00

SI

Mkt Cap

$882.0M

Volume

958.27K

Next Earnings

November 9th

Chart Financials Earnings News About Insider Filings

Why Si-Bone Stock Soared by Almost 20% on TuesdaySi-Bone (SIBN) stock surged nearly 20% on Tuesday following strong first-quarter 2026 results. The medical device company reported $52.6 million in revenue (up 11% YoY) and significantly narrowed its net loss to $4.3 million. The company also received FDA clearance for its iFuse INTRA Ti implant system and raised full-year guidance to $230-233 million, up from the previous $228.5-232.5 million forecast.The Motley Fool · May 12, 2026

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026Smith+Nephew announced it will showcase advanced orthopaedic technologies at AAOS 2026, including its CORI handheld robotic surgical system for hip, knee and shoulder arthroplasty, new trauma solutions like the EVOS plating system, and an expanded ASC portfolio. The company also announced distribution agreements with SI-BONE for pelvic fracture solutions and RMR Ortho for nitinol fixation technology.GlobeNewswire Inc. · Mar 3, 2026

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026Smith+Nephew will showcase its rotator cuff repair portfolio at AAOS 2026, featuring the newly acquired Tendon Seam Repair System and REGENETEN Bioinductive Implant. The company also announced exclusive US distribution agreements with RMR Ortho for A'TOMIC nitinol fixation technology and SI-BONE for their iFuse TORQ portfolio, expanding its orthopedic offerings.GlobeNewswire Inc. · Mar 2, 2026

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025SI-BONE announced preliminary Q4 2025 revenue of $56.2-$56.3 million (~15% growth) and full year 2025 revenue of $200.8-$200.9 million (~20% growth). The company reported ~1,640 active U.S. physicians (18% increase) and cash equivalents of ~$147.7 million with net cash generation of ~$2.0 million in Q4. Final audited results will be provided in late February 2026.GlobeNewswire Inc. · Jan 12, 2026

Why SI-Bone Stock Was Crushing It TodaySI-Bone reported strong Q3 results with 21% revenue growth, narrowed net losses, and increased physician adoption, leading to a significant stock price surge.The Motley Fool · Nov 11, 2025

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of SI-Bone, Inc. Customers Whose Data May Have Been CompromisedSI-Bone reported a data breach on October 1, 2025, potentially exposing sensitive personal information including names, Social Security numbers, and medical details. A law firm is investigating potential legal action on behalf of affected customers.GlobeNewswire Inc. · Oct 3, 2025

4 Recent Earnings Winners Riding Fresh Momentum in MayFour under-the-radar companies - Porch Group, SunOpta, Tutor Perini, and Si-Bone - reported strong earnings in Q1 2025 and are seeing positive momentum in May.Investing.com · May 14, 2025

Here's Why You Should Add Inogen Stock to Your Portfolio NowInogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.Benzinga · Sep 16, 2024

Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?QIAGEN announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, allowing the launch of an advanced PCR-based molecular screening platform to detect malaria and support epidemiological surveillance of Brazil's dengue epidemic. The collaboration is expected to have a positive impact on QIAGEN's market sentiment.Benzinga · Sep 13, 2024

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024SI-BONE, Inc. (SIBN) announced that it will be participating in the upcoming Morgan Stanley Global Healthcare Conference, where management will host a fireside chat on September 4, 2024.GlobeNewswire Inc. · Aug 22, 2024

to start trading

SI

SIBNSI-BONE, Inc. Common Stock

SIBN

Pay with—

Available Balance0.00

Your PositionYou don't own any SIBN yet.

Related Tickers

Earnings